» Articles » PMID: 38589411

Single-cell Multiomics Reveals the Interplay of Clonal Evolution and Cellular Plasticity in Hepatoblastoma

Abstract

Hepatoblastomas (HB) display heterogeneous cellular phenotypes that influence the clinical outcome, but the underlying mechanisms are poorly understood. Here, we use a single-cell multiomic strategy to unravel the molecular determinants of this plasticity. We identify a continuum of HB cell states between hepatocytic (scH), liver progenitor (scLP) and mesenchymal (scM) differentiation poles, with an intermediate scH/LP population bordering scLP and scH areas in spatial transcriptomics. Chromatin accessibility landscapes reveal the gene regulatory networks of each differentiation pole, and the sequence of transcription factor activations underlying cell state transitions. Single-cell mapping of somatic alterations reveals the clonal architecture of each tumor, showing that each genetic subclone displays its own range of cellular plasticity across differentiation states. The most scLP subclones, overexpressing stem cell and DNA repair genes, proliferate faster after neo-adjuvant chemotherapy. These results highlight how the interplay of clonal evolution and epigenetic plasticity shapes the potential of HB subclones to respond to chemotherapy.

Citing Articles

ACSL4 promotes the formation of the proliferative subtype in hepatoblastoma.

Dang W, Li Q, Wang X BMC Cancer. 2025; 25(1):191.

PMID: 39901207 PMC: 11789379. DOI: 10.1186/s12885-025-13592-4.


Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.

Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q Signal Transduct Target Ther. 2024; 9(1):340.

PMID: 39627201 PMC: 11615378. DOI: 10.1038/s41392-024-02030-9.


A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma.

Wu P, Fish M, Hazard F, Zhu C, Vennam S, Walton H Nat Commun. 2024; 15(1):10007.

PMID: 39567523 PMC: 11579301. DOI: 10.1038/s41467-024-53802-4.


Epigenomic heterogeneity as a source of tumour evolution.

Laisne M, Lupien M, Vallot C Nat Rev Cancer. 2024; 25(1):7-26.

PMID: 39414948 DOI: 10.1038/s41568-024-00757-9.


Compensatory evolution of chromosomes and plasmids counteracts the plasmid fitness cost.

Liu Z, Zhao Q, Xu C, Song H Ecol Evol. 2024; 14(8):e70121.

PMID: 39170056 PMC: 11336059. DOI: 10.1002/ece3.70121.


References
1.
Morcrette G, Hirsch T, Badour E, Pilet J, Caruso S, Calderaro J . germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures. Oncoimmunology. 2019; 8(6):e1583547. PMC: 6492969. DOI: 10.1080/2162402X.2019.1583547. View

2.
Wouters J, Kalender-Atak Z, Minnoye L, Spanier K, De Waegeneer M, Gonzalez-Blas C . Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma. Nat Cell Biol. 2020; 22(8):986-998. DOI: 10.1038/s41556-020-0547-3. View

3.
Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B . Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9(9):R137. PMC: 2592715. DOI: 10.1186/gb-2008-9-9-r137. View

4.
Ma H, Zwaan E, Guo Y, Cejas P, Thiru P, van de Bunt M . The nuclear receptor THRB facilitates differentiation of human PSCs into more mature hepatocytes. Cell Stem Cell. 2022; 29(5):795-809.e11. PMC: 9466295. DOI: 10.1016/j.stem.2022.03.015. View

5.
Aronson D, Meyers R . Malignant tumors of the liver in children. Semin Pediatr Surg. 2016; 25(5):265-275. DOI: 10.1053/j.sempedsurg.2016.09.002. View